期刊信息/Journal information
清华大学
马飞
双月刊
2770-9191
10-1951/R73
cancerinnovation@tup.tsinghua.edu.cn
100084
北京市海淀区学研大厦A栋清华大学出版社902室
0
0
Cancer Innovation/Journal 肿瘤学创新(英文)
Cancer Innovation是一本国际性的、同行评议的Open Access英文期刊,聚焦于肿瘤新兴交叉学科、战略前沿及关键共性技术,致力于发表基础研究和临床肿瘤学领域创新且具有重大意义的研究成...展开全部>>
收录年代
Treatment Advances in Gynecologic Cancers:Insights From Recent Clinical Trials
Yiyang Shen;Xiaofei Jiao;Yuanjia Wen;Zikun Peng;Xuejiao Zhao;Jiahao Liu;Qinglei Gao;P.36-47
Practice-Changing Advances in Systemic Therapies Shaping the Landscape of Lung Cancer in 2025
Zhenyu Zhou;Wanting Gao;Molly S.C.Li;Qing Zhou;P.26-35
Clinical Breakthrough in Targeted Protein Degradation:Reflections on the Approval of ARV-471
Yu Rao;P.23-25
Expert Consensus on the Clinical Application of Poly ADP Ribose Polymerase Inhibitors in Breast Cancer(2025 Edition)
Fei Ma;Binghe Xu;China Anti-Cancer Association Committee on Clinical Research of Anticancer Drugs;National Expert Committee on Monitoring Clinical Application of Antineoplastic Drugs;Breast Cancer Expert Committee of National Cancer Quality Control Center;Expert Committee on Chemotherapy Quality Control of Beijing Cancer Treatment Quality Control and Improvement Center;P.9-19
Immunogenic Cell Death:Unlocking New Frontiers in Cancer Immunotherapy
Katherine Yaacoub;P.48-61
Multiple Primary Malignancies in Patients With Gastric Cancer:A Retrospective Study in National Cancer Center of China
Guiling Zhu;Yutong Li;Bingzhi Wang;Liyan Xue;Yuchen Jiao;Xiaobing Wang;Chunxia Du;P.62-71
Constructing Tumor Cellular Cluster Models and Their Evolutionary Dynamics to Decode Tumor Evolution
Haili Qian;Fei Ma;P.20-22
Rationale and Trial Design of DAWNA-FES Trial:Single-Arm Phase Ⅱ Study of Endocrine Therapy With Dalpiciclib After Progression on CDK4/6 Inhibition Based on[^(18)F]FES PET/CT in Patients With HR+/HER2−Advanced Breast Cancer
Ru Yao;Yang Qu;Zhixin Hao;Ying Xu;Jiahui Zhang;Jie Lian;Lu Gao;Songjie Shen;Feng Mao;Bo Pan;Qiang Sun;Li Huo;Yidong Zhou;P.1-8
EDITORIAL BOARD
P.I0001-I0002